Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders

Gynecological Endocrinology

Volumn 29, Issue 3, 2013, Pages 196-200

  Chang, Xiaoxia ^a,b   Wu, Jie ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

in vitro fertilization; Luteal estradiol treatment; Ovarian stimulation; Poor responder

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE;

ARTICLE; CELL COUNT; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; FERTILIZATION IN VITRO; HUMAN; META ANALYSIS; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIAN STIMULATION; OVARY FUNCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE;

COHORT STUDIES; DRUG RESISTANCE; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84874289373     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.736558     Document Type: Article

References (35)

1. Garcia JE, Jones GS, Acosta AA, Wright G. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: Phase II, 1981. Fertil Steril 1983;39:174-179. (Pubitemid 13195405)
2. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-527. (Pubitemid 27240414)
3. Turhan NO. Poor responseYthe devil is in the definition. Fertil Steril 2006;86:777; author reply 777.
4. Mahutte NG, Arici A. Poor responders: Does the protocol make a difference? Curr Opin Obstet Gynecol 2002;14:275-281. (Pubitemid 34557090)
5. Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279-290. (Pubitemid 34618945)
6. Lamazou F, Fuchs F, Grynberg M, Gallot V, Herzog E, Fanchin R, Frydman N, Frydman R. [Cancellation of IVF-ET cycles: Poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimulation? An analysis of 142 cancellations]. J Gynecol Obstet Biol Reprod (Paris) 2012;41:41-47.
7. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: Results of a prospective randomized trial. Hum Reprod 2001;16:868-870. (Pubitemid 32451819)
8. Huirne JAF, van Loenen ACD, Donnez J, Pirard C, Homburg R, Schats R, McDonnell J, Lambalk CB. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: A randomized study. Reprod Biomed Online 2006;13:235-245. (Pubitemid 44207772)
9. Horvath PM, Styler M, Hammond JM, Shelden RM, Kemmann E. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation. Fertil Steril 1988;49:159-162. (Pubitemid 18033911)
10. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352-357. (Pubitemid 43159906)
11. Schachter M, Friedler S, Raziel A, Strassburger D, Bern O, Ron-el R. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phaseYa function of improved embryo quality. J Assist Reprod Genet 2001;18:197-204. (Pubitemid 32574598)
12. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 2003;18:2698-2703. (Pubitemid 37536643)
13. de Ziegler D, Jaaskelainen AS, Brioschi PA, Fanchin R, Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 1998;13:561-564. (Pubitemid 28171945)
14. Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril 2005;84:1023-1026. (Pubitemid 41414601)
15. Frattarelli JL, Hill MJ, McWilliams GD, Miller KA, Bergh PA, Scott RT Jr. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008;89:1118-1122. (Pubitemid 351671736)
16. Chang EM, Han JE, Won HJ, Kim YS, Yoon TK, Lee WS. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. J Assist Reprod Genet 2012;29:225-230.
17. Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z. Stimulation of the young poor responder: Comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. Fertil Steril 2011;95:592-595.
18. Ata B, Zeng X, Son WY, Holzer H, Tan SL. Follicular synchronization using transdermal estradiol patch and GnRH antagonists in the luteal phase; does it increase oocyte yield in poor responders to gonadotropin stimulation for in vitro fertilization (IVF)? A comparative study with microdose flare-up protocol. Gynecol Endocrinol 2011;27:876-879.
19. Hill MJ, McWilliams GD, Miller KA, Scott RT, Frattarelli JL. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertil Steril 2009;91:739-743.
20. Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes. Fertil Steril 2009;92:226-230.
21. Takekida S, Matsuo H, Maruo T. GnRH agonist action on granulosa cells at varying follicular stages. Mol Cell Endocrinol 2003;202:155-164. (Pubitemid 36593407)
22. Yang BC, Uemura T, Minaguchi H. Effects of a gonadotropin releasing hormone agonist on oocyte maturation, fertilization, and embryonal development of mice. J Assist Reprod Genet 1995;12:728-732.
23. Yoshimura Y, Nakamura Y, Ando M, Shiokawa S, Koyama N, Nanno T. Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle. Fertil Steril 1992;57:1091-1097.
24. Fanchin R, Cunha-Filho JS, Schonauer LM, Righini C, de Ziegler D, Frydman R. Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status. Fertil Steril 2003;79:585-589. (Pubitemid 36293456)
25. Fanchin R, Cunha-Filho JS, Schonauer LM, Kadoch IJ, Cohen-Bacri P, Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril 2003;79:316-321. (Pubitemid 36144055)
26. Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 1999;14:1690-1697. (Pubitemid 29358678)
27. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: A systematic review. Hum Reprod Update 2003;9:61-76. (Pubitemid 36305584)
28. Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228-232.
29. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996;65:961-965. (Pubitemid 26126828)
30. Spandorfer S, Navarro J, Kump LM, Liu HC, Davis OK, Rosenwaks Z. "Co-Flare" stimulation in the poor responder patient: Predictive value of the flare response. J Assist Reprod Genet 2001;18:629-633. (Pubitemid 34059806)
31. Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: A retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003;6:439-443. (Pubitemid 36849804)
32. Kailasam C, Keay SD, Wilson P, Ford WC, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 2004;19:1544-1547. (Pubitemid 38997178)
33. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Hum Reprod 1999;14:2959-2962.
34. Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, Xia YX, et al. Gonadotropin-releasing hormone antagonist protocol: A novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 2001;97:202-207. (Pubitemid 32645656)
35. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 2002;17:874-885. (Pubitemid 34411116)